Lipideon Biotechnology AG

Board Member

Board Member

Education

MD

degree
,
Economics

Thomas Hecht, MD, is chairman of Affimed's Supervisory Board since 2007 and Head of HHC consulting in Kuessnacht, Switzerland.He was previously Vice President Marketing at Amgen Europe, Lucerne, Switzerland.A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002.Prior to joining the biopharmaceutical industry, he certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany.
Today, he provides services to the pharmaceutical industry in clinical development/ marketing and licensing strategies through HHC, a biopharmaceutical consulting company founded in 2002.
He also serves as Chairman of the Boards of Cell Medica Ltd., Delenex AG and of the supervisory council of SuppreMol GmbH and as Member of the Board of Humabs BioMed AG.In 2009, with the acquisition by Alcon, he stepped down from the Chairmanship of ESBATech AG.

Dr. Hecht has extensive experience in clinical development and has served on the Board of Directors for several biotech companies including Cytos, ESBAtech, Affimed and Supremol.In addition, Dr. Hecht has held the position of VP Marketing at the European division of Amgen.